Integer (NYSE:ITGR) Price Target Raised to $124.00 at Citigroup

Integer (NYSE:ITGR) had its target price upped by Citigroup from $118.00 to $124.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock.

A number of other research firms have also recently issued reports on ITGR. Bank of America upgraded Integer from a neutral rating to a buy rating and increased their target price for the stock from $105.00 to $135.00 in a report on Monday, April 15th. KeyCorp increased their price objective on Integer from $123.00 to $139.00 and gave the stock an overweight rating in a report on Tuesday, April 9th. CL King assumed coverage on Integer in a research note on Thursday, March 14th. They issued a buy rating and a $137.00 target price on the stock. Truist Financial initiated coverage on shares of Integer in a research note on Wednesday, May 15th. They set a buy rating and a $137.00 price target for the company. Finally, Benchmark reissued a buy rating and issued a $130.00 price objective on shares of Integer in a research report on Friday, May 10th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average price target of $128.00.

Integer Trading Up 0.7 %

NYSE:ITGR opened at $122.63 on Wednesday. The business’s 50-day simple moving average is $115.74 and its 200-day simple moving average is $105.18. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $123.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01. The stock has a market capitalization of $4.11 billion, a PE ratio of 42.43, a price-to-earnings-growth ratio of 1.80 and a beta of 1.12.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The firm had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. During the same quarter in the previous year, the firm posted $0.87 earnings per share. The business’s revenue was up 9.5% on a year-over-year basis. Sell-side analysts expect that Integer will post 5.27 earnings per share for the current fiscal year.

Insider Transactions at Integer

In related news, EVP John A. Harris sold 312 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.00, for a total transaction of $35,256.00. Following the transaction, the executive vice president now directly owns 1,157 shares in the company, valued at $130,741. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, EVP John A. Harris sold 312 shares of Integer stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total transaction of $35,256.00. Following the completion of the transaction, the executive vice president now owns 1,157 shares in the company, valued at $130,741. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Tommy P. Thomas sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $114.00, for a total value of $171,000.00. Following the completion of the sale, the vice president now directly owns 2,813 shares of the company’s stock, valued at $320,682. The disclosure for this sale can be found here. Insiders have sold a total of 6,812 shares of company stock worth $771,956 in the last 90 days. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integer

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in Integer by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,843,992 shares of the medical equipment provider’s stock valued at $301,484,000 after buying an additional 15,300 shares during the last quarter. Victory Capital Management Inc. increased its stake in shares of Integer by 8.9% during the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider’s stock worth $128,041,000 after purchasing an additional 133,898 shares during the period. FMR LLC lifted its holdings in Integer by 12.8% during the 3rd quarter. FMR LLC now owns 863,938 shares of the medical equipment provider’s stock worth $67,759,000 after purchasing an additional 97,851 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its stake in Integer by 497.0% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider’s stock valued at $42,065,000 after purchasing an additional 446,508 shares during the period. Finally, abrdn plc grew its holdings in Integer by 0.6% in the 4th quarter. abrdn plc now owns 520,646 shares of the medical equipment provider’s stock valued at $51,586,000 after buying an additional 3,013 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.